Christopher A. Alabi

6.2k total citations · 2 hit papers
59 papers, 4.4k citations indexed

About

Christopher A. Alabi is a scholar working on Molecular Biology, Organic Chemistry and Microbiology. According to data from OpenAlex, Christopher A. Alabi has authored 59 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 18 papers in Organic Chemistry and 10 papers in Microbiology. Recurrent topics in Christopher A. Alabi's work include Advanced biosensing and bioanalysis techniques (16 papers), RNA Interference and Gene Delivery (13 papers) and Chemical Synthesis and Analysis (13 papers). Christopher A. Alabi is often cited by papers focused on Advanced biosensing and bioanalysis techniques (16 papers), RNA Interference and Gene Delivery (13 papers) and Chemical Synthesis and Analysis (13 papers). Christopher A. Alabi collaborates with scholars based in United States, Italy and United Kingdom. Christopher A. Alabi's co-authors include Mark E. Davis, Chung Hang Jonathan Choi, Jonathan E. Zuckerman, Jeremy D. Heidel, Yun Yen, Anthony W. Tolcher, Antoni Ribas, David B. Seligson, Mintu Porel and Paul Webster and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Christopher A. Alabi

58 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

2010 1.9k citations Christopher A. Alabi et al. profile →
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles

2009 558 citations Christopher A. Alabi et al. profile →

Peers

Countries citing papers authored by Christopher A. Alabi

Since Specialization

Citations

This map shows the geographic impact of Christopher A. Alabi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Alabi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Alabi more than expected).

Fields of papers citing papers by Christopher A. Alabi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Alabi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Alabi. The network helps show where Christopher A. Alabi may publish in the future.

Co-authorship network of co-authors of Christopher A. Alabi

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Alabi. A scholar is included among the top collaborators of Christopher A. Alabi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Alabi. Christopher A. Alabi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of a single-subunit oligosaccharyltransferase that enables glycosylation of full-length IgG antibodies in bacteria 2025 ·Nature Communications ·(unknown), (unknown), Sai Pooja Mahajan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Christopher A. Alabi, Parastoo Azadi, Jeffrey J. Gray, Michael C. Jewett, Lai‐Xi Wang, Matthew P. DeLisa	2
2	Bio-orthogonal Glycan Imaging of Cultured Cells and Whole Animal C. elegans with Expansion Microscopy 2024 ·ACS Central Science ·Joe Chin‐Hun Kuo, Marshall J. Colville, (unknown), (unknown), Li-Shar Huang, (unknown), (unknown), Gunther Hollopeter, Matthew P. DeLisa, Christopher A. Alabi, Matthew J. Paszek	1
3	Bioreversible Anionic Cloaking Enables Intracellular Protein Delivery with Ionizable Lipid Nanoparticles 2024 ·ACS Central Science ·(unknown), (unknown), Matthew P. DeLisa, Christopher A. Alabi	9
4	Synthetically encoded complementary oligomers 2023 ·Nature Reviews Chemistry ·(unknown), (unknown), Christopher A. Alabi	8
5	Discrete Oligocarbamates Exhibit Sequence-Dependent Fluorescence Emission and Quenching 2023 ·ACS Polymers Au ·Emily A. Hoff, (unknown), (unknown), Christopher A. Alabi	5
6	Mechanism of Action and Resistance Evasion of an Antimicrobial Oligomer against Multidrug-Resistant Gram-Negative Bacteria 2022 ·ACS Applied Bio Materials ·(unknown), (unknown), John J. LiPuma, Tobias Dörr, Lars F. Westblade, Christopher A. Alabi	6
7	Design of a PEGylated Antimicrobial Prodrug with Species-Specific Activation 2021 ·Biomacromolecules ·(unknown), (unknown), Lars F. Westblade, Christopher A. Alabi	9
8	PEGylated Oligothioetheramide Prodrugs Activated by Host Serum Proteases 2021 ·ChemBioChem ·(unknown), (unknown), (unknown), Christopher A. Alabi	5
9	Characterization of 14-Crown-4 Ethers for the Extraction of Lithium from Natural Brines: Synthesis, Solubility Measurements in Supercritical Carbon Dioxide, and Thermodynamic Modeling 2021 ·Industrial & Engineering Chemistry Research ·(unknown), Christopher A. Alabi, Jefferson W. Tester	11
10	Decomplexation as a rate limitation in the thiol-Michael addition of N-acrylamides 2020 ·Organic & Biomolecular Chemistry ·Joseph S. Brown, (unknown), (unknown), Christopher A. Alabi, Paulette Clancy	5
11	Antibody-Mediated Endocytosis of Polysialic Acid Enables Intracellular Delivery and Cytotoxicity of a Glycan-Directed Antibody–Drug Conjugate 2019 ·Cancer Research ·(unknown), (unknown), (unknown), (unknown), Judith H. Merritt, Matthew J. Paszek, Christopher A. Alabi, Matthew P. DeLisa	16
12	Substrate Design Enables Heterobifunctional, Dual “Click” Antibody Modification via Microbial Transglutaminase 2019 ·Bioconjugate Chemistry ·Joshua A. Walker, (unknown), Francis Ledesma, (unknown), (unknown), (unknown), Christopher A. Alabi	29
13	Dual Site-Specific Antibody Conjugates for Sequential and Orthogonal Cargo Release 2019 ·Bioconjugate Chemistry ·(unknown), (unknown), Joshua A. Walker, (unknown), (unknown), Matthew P. DeLisa, Christopher A. Alabi	31
14	Biophysical Characterization of Cationic Antibacterial Oligothioetheramides 2019 ·Analytical Chemistry ·(unknown), Joseph S. Brown, Christopher A. Alabi	9
15	Design of protein-based “turn on” molecular probes for intracellular bond cleavage 2019 ·Molecular Systems Design & Engineering ·(unknown), Joshua A. Walker, Francis Ledesma, (unknown), Christopher A. Alabi	3
16	Antibacterial isoamphipathic oligomers highlight the importance of multimeric lipid aggregation for antibacterial potency 2018 ·Communications Biology ·Joseph S. Brown, (unknown), (unknown), (unknown), (unknown), (unknown), Susan Daniel, Christopher A. Alabi	20
17	Intracellular Delivery via Noncharged Sequence-Defined Cell-Penetrating Oligomers 2018 ·Bioconjugate Chemistry ·(unknown), (unknown), Christopher A. Alabi	9
18	Sensitivity of Antibacterial Activity to Backbone Sequence in Constitutionally Isomeric OligoTEAs 2018 ·Macromolecular Bioscience ·Emily A. Hoff, (unknown), Joseph S. Brown, Christopher A. Alabi	11
19	Sequence-Defined Backbone Modifications Regulate Antibacterial Activity of OligoTEAs 2017 ·ACS Chemical Biology ·Mintu Porel, (unknown), (unknown), Christopher A. Alabi	50
20	Versatile Platform for the Synthesis of Orthogonally Cleavable Heteromultifunctional Cross-Linkers 2017 ·Bioconjugate Chemistry ·(unknown), Joshua A. Walker, Joseph S. Brown, Christopher A. Alabi	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact